Not a good buy right now: price is selling off hard (-9.90% regular session, additional -4.50% pre-market), and momentum indicators are bearish.
No Intellectia proprietary “strong buy” triggers (no AI Stock Picker, no SwingMax), so there’s no signal-based reason to step in aggressively today.
Earnings are imminent (2026-02-13 pre-market), and with no revenue plus large losses, the risk/reward for an impatient entry is unfavorable.
Options flow is call-heavy (bullish/speculative sentiment), but elevated IV suggests the market is pricing big moves—this can amplify downside if earnings/news disappoint.
Technical Analysis
Trend/momentum: Bearish near-term momentum; MACD histogram is negative (-0.073) and expanding lower, consistent with weakening price action.
RSI: RSI(6) at ~41.7 is neutral-to-weak (not oversold), implying room for further downside before a mean-reversion bounce becomes compelling.
Moving averages: Converging MAs suggest a transition phase, but today’s sharp drop tilts that transition bearish.
Key levels: Pivot 6.892 is well above the current 6.01 (lost the pivot = bearish). Immediate support S1 ~5.944 is very close; a clean break below raises risk toward S2 ~5.359. Resistance zones: 6.892 then 7.839.
Pattern/stat tilt: Similar-pattern stats show modest upside bias over 1 week to 1 month, but today’s breakdown makes timing poor for an immediate buy unless support cleanly holds and reverses.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Put/Call ratios (OI and volume both 0.18) indicate strongly call-skewed sentiment (bullish/speculative).
Activity: Today’s option volume (4,538) is below the 5D/10D averages, but open interest is large (total OI ~147,809), implying the market is already heavily positioned.
Volatility: Very high IV (30D 133.93) vs high historical vol (121.15), with IV percentile ~67—options are expensive and the market expects a large move (often tied to upcoming earnings/catalysts).
Takeaway: Options sentiment is bullish, but elevated IV + earnings proximity increases gap-risk; this supports “avoid chasing shares today” rather than “buy now.”
Technical Summary
Sell
6
Buy
8
Positive Catalysts
holds and price reclaims the 6.892 pivot, a technical relief rally becomes more plausible.
Neutral/Negative Catalysts
Price action: Sharp selloff today and weak pre-market continuation signals current sellers are in control.
Earnings event risk: Next earnings (2026-02-13 pre-market) introduces near-term uncertainty and potential gap-down if results/cash outlook disappoint.
News flow: Rare earth/critical minerals names weakened on reports of retreat from critical mineral price floors—policy backdrop reads as a sentiment headwind for the group.
Fundamentals: Lack of revenue and deep losses reduce “floor” support if risk-off accelerates.
Financial Performance
Latest quarter: 2026/Q1.
Revenue: Reported as 0 (no operating revenue), indicating the company is still pre-revenue.
Profitability: Net income at -42,659,000 (loss) with a large YoY deterioration ("up" 1959.83% in magnitude), signaling losses expanded materially.
EPS: -0.56 (loss per share). Even if the data labels it as “increased,” it remains deeply negative and is not supportive of an immediate buy ahead of earnings.
Overall: Financial trend does not currently show operating momentum; the stock is trading more on optionality/catalysts than on improving fundamentals.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent change: [2026-01-07] Freedom Capital initiated coverage with a Buy; stock jumped to ~$6.86 on that news.
Trend: Only one noted recent rating item—net tone is supportive, but coverage breadth appears limited from the provided data.
Wall Street pros: Initiation Buy can attract incremental interest; critical minerals theme can drive upside if catalysts hit.
Wall Street cons: Limited visibility, pre-revenue profile, and large losses make it hard to underwrite near-term value; near-term price action is contradicting the bullish initiation.
Wall Street analysts forecast NB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NB is 12.25 USD with a low forecast of 9.5 USD and a high forecast of 15 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast NB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NB is 12.25 USD with a low forecast of 9.5 USD and a high forecast of 15 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 5.740
Low
9.5
Averages
12.25
High
15
Current: 5.740
Low
9.5
Averages
12.25
High
15
Freedom Capital
initiated
$6.86
AI Analysis
2026-01-07
Reason
Freedom Capital
Price Target
$6.86
AI Analysis
2026-01-07
initiated
Reason
NioCorp jumps 6% to $6.86 after Freedom Capital starts with Buy
William Blair
William Blair
Outperform
initiated
2025-10-20
Reason
William Blair
William Blair
Price Target
2025-10-20
initiated
Outperform
Reason
William Blair initiated coverage of NioCorp with an Outperform rating and no price target. The firm says the company is getting close to a three-year construction project that would result in it producing designated critical minerals niobium, titanium,scandium, and, potentially, magnetic rare earth oxides. NioCorp's Elk Creek project is unique because of its ore body, featuring multiple potential products that can be produced, the analyst tells investors in a research note. Blair believes the U.S. government could provide financing and take a stake in NioCorp.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for NB
